Ron DeSantis Highlights Monoclonal Antibodies Treatment As Media Tries To Ignore It

(PresidentialInsider.com)- While meeting with officials from Tampa General Hospital and the University of South Florida Health Morsani College of Medicine last Thursday, Governor Ron DeSantis discussed the efficacy of monoclonal antibody treatments for patients with COVID-19.

While monoclonal antibodies have been used in treating COVID-19 for the better part of 2021, DeSantis pointed out that this treatment has not been receiving much attention – despite the fact that results have been “very positive,” the Governor added.

Monoclonal antibody treatment gives the COVID-sufferer’s body the ability to fight back against the virus. Results from the trials showed a 70 percent reduction in hospitalization or death among those undergoing the therapy.

According to John Couris, President and CEO of Tampa General, the monoclonal antibody therapy, while effective, is less known. Currently doctors at Tampa General Hospital, USF as well as private practice physicians are using the treatment “very successfully on positive COVID-19 patients.”

Tampa General and USF were the first hospital system in Florida to offer monoclonal antibodies on COVID patients. And according to Dr. Kami Kim from Tampa General and USF College of Medicine, over sixteen hundred patients have been treated with monoclonal antibodies. Referring to the antibodies as “neutralizing antibodies,” Dr. Kim explained that the monoclonal antibody therapy prevents the COVID-19 virus from infecting cells – in short, it neutralizes the virus.

Dr. Kim said that both in their studies and studies across the country show the treatment to be very effective, adding that it is important to receive monoclonal antibody treatments early on after contracting COVID-19 – generally within seven days after symptoms appear.

Dr. Charles Lockwood, Dean of Morsani College of Medicine, reiterated that the COVID vaccines are about 90 percent effective at protecting someone from hospitalization, death or from long-term COVID symptoms. Those vaccinated have about a 70 percent protection against mild to moderate infections.

Dr. Lockwood also pointed out that, among vaccinated individuals, the current wave of COVID is more similar to an influenza season.

The full video of the press conference can be viewed HERE.